Full Text View
Tabular View
No Study Results Posted
Related Studies
42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
This study has been completed.
Study NCT01381094   Information provided by Akebia Therapeutics

First Received on June 23, 2011.   Last Updated on October 3, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anemia
Kidney Disease
Additional conditions recognized in this trial
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Hematologic Diseases
Renal Insufficiency
Urologic Diseases
Interventions listed in this trial
AKB-6548
Placebo
Sponsors listed in this trial
Akebia Therapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services